NDC 80425-0507-01 - CHLORZOXAZONE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0507
- Requested NDC
- 80425-0507-01
- Package NDCs from labels
- 80425-0507-1, 80425-0507-2, 80425-0507-3, 80425-0507-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2025-03-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CHLORZOXAZONE - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2025-03-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0507-1 | CHLORZOXAZONE | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 80425-0507-2 | CHLORZOXAZONE | 60 in 1 BOTTLE | TABLET | 60 | 1 | |
| 80425-0507-3 | CHLORZOXAZONE | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0507 | CHLORZOXAZONE TABLET [ADVANCED RX OF TENNESSEE, LLC] | 1 | Current NDC, 3 package rows | 20250322_30c9b3ce-198d-0c16-e063-6394a90a857d.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0507-1 | EA - Each | 80425-0507 | 90db2596-d4b9-4bce-97ca-3453f24ef58f | 1 | 2025-05-14 |
| 80425-0507-2 | EA - Each | 80425-0507 | dc53fbe8-bd7e-4d12-b134-8cc1b9a5f444 | 1 | 2025-05-14 |
| 80425-0507-3 | EA - Each | 80425-0507 | e8840893-9961-4080-b38f-48207fa9e308 | 1 | 2025-05-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DOCUZEN | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Proficient Rx LP | 92879e62-f60a-4ab4-9532-610cdd2628ee | 2023-11-01 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | A-S Medication Solutions | 5999904a-6ac8-4d9e-951c-6e64e8cd93eb | 2023-11-01 | Warnings | F05Q2T2JA0 |
| Sodium phenylacetate and Sodium benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Zydus Pharmaceuticals USA Inc. | 0f17c50f-3761-4470-bf3b-63837a287b8a | 2023-10-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Stool Softener Docusate Sodium | DOCUSATE SODIUM | Magno-Humphries, Inc. | a0e6ab9b-fd31-45fd-93d5-b51d705c180a | 2023-10-27 | Warnings | F05Q2T2JA0 |
| Stool Softener Docusate Sodium | DOCUSATE SODIUM | Magno-Humphries, Inc. | 9d22d642-8aed-d17e-e053-2995a90ae182 | 2023-10-27 | Warnings | F05Q2T2JA0 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Magno-Humphries, Inc. | 9deaf264-6af0-40ba-e053-2a95a90ada0e | 2023-10-27 | Warnings | F05Q2T2JA0 |
| DOK | DOCUSATE SODIUM | MAJOR PHARMACEUTICALS | 7a92070d-98cc-662f-e053-2991aa0aa1b2 | 2023-10-23 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | KROGER COMPANY | a1afaa71-7e8c-5a49-e053-2a95a90a4db0 | 2023-10-23 | Warnings | F05Q2T2JA0 |
| SENNA-S | SENNA AND DOCUSATE SODIUM TABLETS, 8.6 MG AND 50 MG | HealthLife of USA LLC | 02a5299c-4b0d-47ac-9838-afd0b0fdd4a6 | 2023-10-21 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | Geri-Care Pharmaceutical Corp | 644d81ec-d38f-4172-a087-727b94e2fefe | 2023-10-19 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | Asclemed USA, Inc. | 30fc8c07-c26b-4bcc-a727-6e193f5727fd | 2023-10-16 | Warnings | F05Q2T2JA0 |
| Stool Softener Extra Strength | DOCUSATE SODIUM | MEIJER, INC. | e43bd2ed-17c7-4530-af72-81a7ad70069c | 2023-10-12 | Warnings | F05Q2T2JA0 |
| Stool Softener Plus Stimulant Laxative | DOCUSATE SODIUM AND SENNOSIDES | Care One (Retail Business Services, LLC.) | 9adaec97-43e3-48f2-96c8-c508b693676c | 2023-10-05 | Warnings | F05Q2T2JA0 |
| CHLORZOXAZONE | CHLORZOXAZONE | Aurobindo Pharma Limited | 52d3aa2c-f88f-4de7-b5ae-df8a46e94879 | 2023-09-05 | Warnings, Adverse reactions | 1088936 1088934 197502 H0DE420U8G |
| Lipotox | SQUALENE, CHOLESTERINUM, ESTRADIOL, PROGESTERONE, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, | BioActive Nutritional, Inc. | a1538692-ca00-4e52-9b7e-409767ee27e1 | 2023-09-05 | Warnings | OJ245FE5EU |
| Chlorzoxazone | CHLORZOXAZONE | Mayne Pharma Commercial LLC | 5238c99e-d36e-4376-ab05-ca2535213d58 | 2023-07-06 | Warnings, Adverse reactions | 1088936 1088934 197502 H0DE420U8G |
| SODIUM PHENYLACETATE AND SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | MAIA PHARMACEUTICALS, INC | 3529be10-0004-4628-9ca1-67a8acd86b51 | 2023-07-05 | Warnings, Adverse reactions | OJ245FE5EU |
| CHLORZOXAZONE | CHLORZOXAZONE | Rising Pharma Holdings, Inc. | 1df6058b-7bf2-4246-9827-93fa023a5fd4 | 2023-06-09 | Warnings, Adverse reactions | ANDA213126 16571-726 1088936 1088934 197502 b4a7f61d-613e-4d8f-a3fc-37143c6e19c3 1df6058b-7bf2-4246-9827-93fa023a5fd4 H0DE420U8G |
| Chlorzoxazone | CHLORZOXAZONE | Bryant Ranch Prepack | 267a0a2a-b818-47d9-9b61-28be172de99a | 2023-05-25 | Warnings, Adverse reactions | 197502 H0DE420U8G |
| CHLORZOXAZONE | CHLORZOXAZONE | Cintex Services, LLC | c95f39c4-0c11-966a-e053-2a95a90a2c18 | 2023-05-23 | Warnings, Adverse reactions | H0DE420U8G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.